"We look forward to working with lawmakers to hold Secretary Kennedy to his promise to maintain our nation's vaccine approval ...

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

The volume of recent flu infections and related hospitalizations is higher than what Sonoma County epidemiologists have ...

Sonya Stokes, an emergency room physician in the San Francisco Bay Area, braces herself for a daily deluge of patients sick ...

They're most effective when they're given at the right time — and lots of careful consideration goes into deciding when exactly that is.[1]#1 In coming up with the best vaccine schedule for your baby, ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...

President Trump on Friday signed two executive orders seeking to strip funding from schools with COVID-19 vaccine mandates and to establish a new council focused on “Energy Dominance.” ...

Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against ...

Moderna MRNA incurred a loss of $2.50 per share in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...

Your little bundle will get this when she is just a newborn and a few times after. Here's why and what to expect.

Chief Executive Stephane Bancel says Moderna will work with the Trump administration. Moderna stock rose in midday trades.